These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4045966)

  • 1. Clinical features of homozygous alpha 2(I) collagen deficient osteogenesis imperfecta.
    Gage JP
    J Med Genet; 1985 Aug; 22(4):319-20. PubMed ID: 4045966
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinical features of homozygous alpha 2(I) collagen deficient osteogenesis imperfecta.
    Nicholls AC; Osse G; Schloon HG; Lenard HG; Deak S; Myers JC; Prockop DJ; Weigel WR; Fryer P; Pope FM
    J Med Genet; 1984 Aug; 21(4):257-62. PubMed ID: 6492090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features of homozygous alpha 2(I) collagen deficient osteogenesis imperfecta.
    Pope FM; Nicolls AC; Osse G; Lee KW
    J Med Genet; 1986 Aug; 23(4):377. PubMed ID: 3746849
    [No Abstract]   [Full Text] [Related]  

  • 4. Heterogeneity of osteogenesis imperfecta type I.
    Paterson CR; McAllion S; Miller R
    J Med Genet; 1983 Jun; 20(3):203-5. PubMed ID: 6876111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splice site mutation causing deletion of exon 21 sequences from the pro alpha 2(I) chain of type I collagen in a patient with severe dentinogenesis imperfecta but very mild osteogenesis imperfecta.
    Nicholls AC; Oliver J; McCarron S; Winter GB; Pope FM
    Hum Mutat; 1996; 7(3):219-27. PubMed ID: 8829655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Osteogenesis imperfecta and dentinogenesis imperfecta. Apropos of 4 cases].
    Ajacques JC; Farge P; Kerebel B
    Rev Stomatol Chir Maxillofac; 1989; 90(4):259-67. PubMed ID: 2762744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild dental findings associated with severe osteogenesis imperfecta due to a point mutation in the alpha 2(I) collagen gene demonstrate different expression of the genetic defect in bone and teeth.
    Luder HU; van Waes H; Raghunath M; Steinmann B
    J Craniofac Genet Dev Biol; 1996; 16(3):156-63. PubMed ID: 8872706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dental findings in osteogenesis imperfecta: I. Occurrence and expression of type I dentinogenesis imperfecta.
    Lukinmaa PL; Ranta H; Ranta K; Kaitila I
    J Craniofac Genet Dev Biol; 1987; 7(2):115-25. PubMed ID: 3624417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical heterogeneity of osteogenesis imperfecta: New variant.
    Nicholls AC; Pope FM; Schloon H
    Lancet; 1979 Jun; 1(8127):1193. PubMed ID: 86915
    [No Abstract]   [Full Text] [Related]  

  • 10. Heterogeneity of osteogenesis imperfecta congenita.
    Pope FM; Nicholls AC
    Lancet; 1980 Apr; 1(8172):820-1. PubMed ID: 6102696
    [No Abstract]   [Full Text] [Related]  

  • 11. Osteogenesis imperfecta and dentinogenesis imperfecta: associated disorders.
    Rios D; Vieira AL; Tenuta LM; Machado MA
    Quintessence Int; 2005 Oct; 36(9):695-701. PubMed ID: 16163872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Osteogenesis imperfecta: presentation of 3 clinical cases].
    de Borgarello LT; de Hidalgo PK; de Leikij BK
    Rev Asoc Odontol Argent; 1983 Sep; 71(5):144-9. PubMed ID: 6587459
    [No Abstract]   [Full Text] [Related]  

  • 13. Disrupted growth plates and progressive deformities in osteogenesis imperfecta as a result of the substitution of glycine 585 by valine in the alpha 2 (I) chain of type I collagen.
    Cole WG; Chan D; Chow CW; Rogers JG; Bateman JF
    J Med Genet; 1996 Nov; 33(11):968-71. PubMed ID: 8950681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical variability of osteogenesis imperfecta linked to COL1A2 and associated with a structural defect in the type I collagen molecule.
    Superti-Furga A; Pistone F; Romano C; Steinmann B
    J Med Genet; 1989 Jun; 26(6):358-62. PubMed ID: 2567784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serine for glycine substitutions in the C-terminal third of the alpha 1(I) chain of collagen I in five patients with nonlethal osteogenesis imperfecta.
    Lund AM; Skovby F; Schwartz M
    Hum Mutat; 1997; 9(4):378-82. PubMed ID: 9101304
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dentinogenesis imperfecta].
    Jasmin JR
    Pedod Fr; 1979; 13():95-100. PubMed ID: 400009
    [No Abstract]   [Full Text] [Related]  

  • 17. Transgenic mouse model of the mild dominant form of osteogenesis imperfecta.
    Bonadio J; Saunders TL; Tsai E; Goldstein SA; Morris-Wiman J; Brinkley L; Dolan DF; Altschuler RA; Hawkins JE; Bateman JF
    Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7145-9. PubMed ID: 2402497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta.
    Chipman SD; Sweet HO; McBride DJ; Davisson MT; Marks SC; Shuldiner AR; Wenstrup RJ; Rowe DW; Shapiro JR
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1701-5. PubMed ID: 8446583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Osteogenesis imperfecta and dentinogenesis imperfecta: diagnostic frontiers and importance in dentofacial orthopedics].
    Kamoun-Goldrat AS; Le Merrer MF
    Orthod Fr; 2007 Jun; 78(2):89-99. PubMed ID: 17580062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A deletion in the gene encoding sphingomyelin phosphodiesterase 3 (Smpd3) results in osteogenesis and dentinogenesis imperfecta in the mouse.
    Aubin I; Adams CP; Opsahl S; Septier D; Bishop CE; Auge N; Salvayre R; Negre-Salvayre A; Goldberg M; Guénet JL; Poirier C
    Nat Genet; 2005 Aug; 37(8):803-5. PubMed ID: 16025116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.